Help Ensure Your Pradaxa Patients Don't Need the New Reversal Agent, Praxbind

December 2015

You'll hear buzz about the new IV med, Praxbind (PRAKS-bynd, idarucizumab) to reverse life-threatening bleeding caused by Pradaxa.

This is a big deal. We know that vitamin K reverses bleeding due to warfarin...but it doesn't work with the newer oral anticoagulants such as Pradaxa (dabigatran).

Up until now, managing bleeding with Pradaxa and other newer anticoagulants has been limited to stopping the drug, supportive care, and using blood products in the hospital.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Errors Report Errors and Near Misses to Prevent Repeat Mishaps
Recalls Help Auvi-Q Patients Find a Replacement Epinephrine Auto-Injector
Practice Avoid Medical Jargon when Gathering Med Lists from Patients
Aspirin Think of Durlaza as an Expensive Way to Get Low-Dose Aspirin
Alcohol Double-Check to see if Liquid Meds Contain Alcohol
Metformin Watch for Patients Skipping Refills on Their Metformin Rxs
COPD an increase in Spiriva Respimat (tiotropium) Rxs now that it's approved for asthma
Supplements Have Patients Check With Your Pharmacist BEFORE Purchasing a Supplement
Elderly Patients Watch for Seniors Taking Risky Medications
Compounding Keep Gram and Milligram Weights Straight When Compounding Meds
Cardiology Help Ensure Your Pradaxa Patients Don't Need the New Reversal Agent, Praxbind

Help Ensure Your Pradaxa Patients Don't Need the New Reversal Agent, Praxbind

Practical advice for a better career, with unlimited access to CE

Table of Contents